https://www.selleckchem.com/MEK.html
INTRODUCTION The eighth edition of the American Joint Committee on Cancer (AJCC8) Staging Manual provides important information for staging and prognostication; however, survival estimates for patients with Stage I-III Merkel cell carcinoma (MCC), a rare disease, may be as practical using data from large-volume centers as that collated for the AJCC analysis. As such, we compared our institutional outcomes to AJCC8. METHODS Patients who presented from 2005 to 2017 with MCC to two high-volume centers were included. Demographics, clinicopathologic char